Cargando…

Cervical cancer screening in Sweden 2014-2016

BACKGROUND: To enable incremental optimization of screening, regular reporting of quality indicators is required. AIM: To report key quality indicators and basic statistics about cervical screening in Sweden. METHODS: We collected individual level data on all cervical cytologies, histopathologies, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Hortlund, Maria, Elfström, K. Miriam, Sparén, Pär, Almstedt, Pouran, Strander, Björn, Dillner, Joakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296530/
https://www.ncbi.nlm.nih.gov/pubmed/30557367
http://dx.doi.org/10.1371/journal.pone.0209003
_version_ 1783381052323004416
author Hortlund, Maria
Elfström, K. Miriam
Sparén, Pär
Almstedt, Pouran
Strander, Björn
Dillner, Joakim
author_facet Hortlund, Maria
Elfström, K. Miriam
Sparén, Pär
Almstedt, Pouran
Strander, Björn
Dillner, Joakim
author_sort Hortlund, Maria
collection PubMed
description BACKGROUND: To enable incremental optimization of screening, regular reporting of quality indicators is required. AIM: To report key quality indicators and basic statistics about cervical screening in Sweden. METHODS: We collected individual level data on all cervical cytologies, histopathologies, human papillomavirus tests and all invitations for cervical screening in Sweden during 2013–2016. RESULTS: There were over 2,278,000 cervical samples collected in Sweden in 2014–2016. Organized samples (resulting from an invitation) constituted 69% of samples. The screening test coverage of all resident women aged 23–60 was 82%. The coverage has slowly increased for >10 years. There is large variability between counties (from 71% to 92%) over time. There were 25,725 women with high-grade lesions in cytology during 2013–2015. Only 96% of these women had a follow-up histopathology within a year. Cervical cancer incidence showed an increasing trend. CONCLUSION: Key quality indicators such as population coverage and follow-up rates were stable or improving, but there was nevertheless an unexplained cervical cancer increase.
format Online
Article
Text
id pubmed-6296530
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62965302018-12-28 Cervical cancer screening in Sweden 2014-2016 Hortlund, Maria Elfström, K. Miriam Sparén, Pär Almstedt, Pouran Strander, Björn Dillner, Joakim PLoS One Research Article BACKGROUND: To enable incremental optimization of screening, regular reporting of quality indicators is required. AIM: To report key quality indicators and basic statistics about cervical screening in Sweden. METHODS: We collected individual level data on all cervical cytologies, histopathologies, human papillomavirus tests and all invitations for cervical screening in Sweden during 2013–2016. RESULTS: There were over 2,278,000 cervical samples collected in Sweden in 2014–2016. Organized samples (resulting from an invitation) constituted 69% of samples. The screening test coverage of all resident women aged 23–60 was 82%. The coverage has slowly increased for >10 years. There is large variability between counties (from 71% to 92%) over time. There were 25,725 women with high-grade lesions in cytology during 2013–2015. Only 96% of these women had a follow-up histopathology within a year. Cervical cancer incidence showed an increasing trend. CONCLUSION: Key quality indicators such as population coverage and follow-up rates were stable or improving, but there was nevertheless an unexplained cervical cancer increase. Public Library of Science 2018-12-17 /pmc/articles/PMC6296530/ /pubmed/30557367 http://dx.doi.org/10.1371/journal.pone.0209003 Text en © 2018 Hortlund et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hortlund, Maria
Elfström, K. Miriam
Sparén, Pär
Almstedt, Pouran
Strander, Björn
Dillner, Joakim
Cervical cancer screening in Sweden 2014-2016
title Cervical cancer screening in Sweden 2014-2016
title_full Cervical cancer screening in Sweden 2014-2016
title_fullStr Cervical cancer screening in Sweden 2014-2016
title_full_unstemmed Cervical cancer screening in Sweden 2014-2016
title_short Cervical cancer screening in Sweden 2014-2016
title_sort cervical cancer screening in sweden 2014-2016
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296530/
https://www.ncbi.nlm.nih.gov/pubmed/30557367
http://dx.doi.org/10.1371/journal.pone.0209003
work_keys_str_mv AT hortlundmaria cervicalcancerscreeninginsweden20142016
AT elfstromkmiriam cervicalcancerscreeninginsweden20142016
AT sparenpar cervicalcancerscreeninginsweden20142016
AT almstedtpouran cervicalcancerscreeninginsweden20142016
AT stranderbjorn cervicalcancerscreeninginsweden20142016
AT dillnerjoakim cervicalcancerscreeninginsweden20142016